Table 3.
Explanatory variable | Patients with Angina after AMI | Patients without Angina after AMI | ||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Before adjustment for patient characteristicsa | After adjustment for patients characteristicsb | Before adjustment for patient characteristicsa | After adjustment for patients characteristicsb | |||||
| ||||||||
Coefficient | P value | Coefficient | P value | Coefficient | P value | Coefficient | P value | |
Female (vs. male) | 3.31 | <.001 | 1.72 | <.001 | 3.20 | <.001 | 1.80 | <.001 |
Time | ||||||||
1 month (vs. baseline) | −3.20 | <.001c | −1.40 | <.001c | −4.69 | <.001c | −2.72 | <.001c |
12 months (vs. baseline) | −3.95d | <.001c | −1.88e | <.001c | −5.45f | <.001c | −3.10g | <.001c |
Coefficient estimates and p values were based on results from multivariable linear mixed effects models to account for correlation in repeated measures within the same individual over time.
Model adjusted for patient sex, time, and country.
Model adjusted for patient’s sex, time, and country; baseline age, race, education, marital status, number of children living in household, financial status, employment status, and number of comorbid conditions at baseline; AMI characteristics at initial admission, including ST-segment-elevation myocardial infarction (STEMI) versus non-STEMI, cardiogenic shock upon hospital admission, ejection fraction <40%, Global Registry of Acute Coronary Events (GRACE) risk score >99, hemodynamic instability on arrival, presentation to the hospital >6 hours after symptom onset, and length of stay during the initial hospitalization; and time-varying measures of Seattle Angina Questionnaire (SAQ) angina-related physical limitation score, the INTERHEART stressful life events scale, low social support determined by the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Social Support Inventory (ESSI), and depression based on the Patient Health Questionnaire (PHQ-9).
P value adjusted with step-down Bonferroni.
Implied a difference of −0.75 between 1-month and 12-month follow-up (p=0.04).
Implied a difference of −0.48 between 1-month and 12-month follow-up (p=0.48).
Implied a difference of −0.76 between 1-month and 12-month follow-up (p=.007).
Implied a difference of −0.38 between 1-month and 12-month follow-up (p=0.73).